Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2009
10/28/2009CN100554278C Human tumor M2-type pyruvate kinase antigen determinant polypeptide and antibody and their application in diagnositic kit
10/28/2009CN100553944C Apparatus and process for the formation of a film or fiber
10/27/2009US7610156 Methods for rational pegylation of proteins
10/27/2009US7610155 Methods for processing spectral data for enhanced embryo classification
10/27/2009US7610154 Method and apparatus for chemical genetic programming
10/27/2009US7610153 Multi-drug titration and evaluation
10/27/2009US7609547 Biosensor and sensing cell array using the same
10/27/2009US7609369 Methods of detection of iron deficiency and hemochromatosis
10/27/2009US7608840 System and method employing photokinetic techniques in cell biology imaging applications
10/27/2009US7608749 Monitoring APP cleavage in transgenic rodents comprising an APP Swedish mutation
10/27/2009US7608707 siRNA targeting survivin
10/27/2009US7608697 Mixture comprising enzymatic polypeptides with proline modified terminal for use in enhancing/reducing digestion/flavor/bitterness of foods; food processing
10/27/2009US7608696 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents
10/27/2009US7608695 Substance with antithrombotic activity and method for detecting glycokallidin
10/27/2009US7608682 Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608591 Targeted delivery to legumain-expressing cells
10/27/2009US7608586 Binding may be used to detect A beta or to separate A beta from the rest of a subject's body; in Alzheimer's disease, it may be used to provide diagnostic results by detecting A beta , treatment by removing A beta , or both
10/27/2009US7608466 Process and device for producing reagent carriers
10/27/2009US7608465 Multi-analyte diagnostic test for thyroid disorders
10/27/2009US7608463 Optical assay apparatus having an optical filter, an optical sensor with a light ray redirection portion, an assay sensing portion, and a filter to block certain wavelengths of excitation light rays and to pass certain wavelengths of signal recovery light rays from the optical sensor
10/27/2009US7608462 Drying SPE cartridges
10/27/2009US7608459 Determining the effectiveness of a deodorant by detecting 1,2-amino-7-hydroxy-5-methyl-5-propyl-4-thiaheptanoic acid
10/27/2009US7608458 Identifying patients at risk for life threatening arrhythmias
10/27/2009US7608457 Blood collection and testing improvements
10/27/2009US7608453 Intracellular antibodies
10/27/2009US7608452 Polynucleotides encoding cytokine receptor zcytor19
10/27/2009US7608416 Targeting mPGES-1 as a treatment for inflammation which avoids cardiovascular risk
10/27/2009US7608414 Method for diagnosing and prognosing inflammatory bowel disease and crohn's disease
10/27/2009US7608413 Kidney disease targets and uses thereof
10/27/2009US7608412 Measuring the amount of p62 protein in a cortical brain tissue sample and comparing to a control where measured amount of p62 protein is fifty percent or less than the amount in the control
10/27/2009US7608411 Prostaglandin receptor EP1
10/27/2009US7608410 Method of improving T cell receptors
10/27/2009US7608409 Screening assay using G-protein coupled receptor protein OT7T175
10/27/2009US7608408 Methods of identifying compounds that inhibit Notch cleavage
10/27/2009US7608407 Fluorescence polarization assay for determining histidine decarboxylase activity
10/27/2009US7608406 Diagnostic markers of stroke and cerebral injury and methods of use thereof
10/27/2009US7608405 Distinguishing target adiponectin multimer from the other adiponectin multimers by using a protease and/or an antibody; accurately evaluate the relationship between a disease and adiponectin
10/27/2009US7608404 urinalysis; pretreatment to add an acidic or alkaline solution and to heat the sample, excitation light irradiation process to irradiate the sample with the excitation light and to continuously or intermittently change the wavelength of the excitation light,emission light measurement, data analysis
10/27/2009US7608403 Method for cancer detection, progression analysis and malign tumour prognosis based on the study of metabolic markers of the cell
10/27/2009US7608401 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
10/27/2009US7608397 Using variation in dielectric constant as tool in detecting change in conformational or energetic state of molecular species
10/27/2009US7608393 Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients
10/27/2009US7608392 Diagnostic assay for measuring a cell mediated immune response
10/27/2009US7608389 Photoresists processable under biocompatible conditions for multi-biomolecule patterning
10/27/2009US7608263 RG1 antibodies and uses thereof
10/27/2009US7608259 Methods of cancer diagnosis and therapy targeted against a cancer stem line
10/27/2009US7608246 combination of apolipoprotein E and an antigenic lipid administered to a subject for the purpose of inducing an immune response against the lipid and in immunization protocols
10/27/2009US7608245 Transmission and, or amplification of signal ; oral or enteric administering; dissolving; absorption by small inteestines; peptide yy; obesity therapy
10/27/2009US7608242 Peptide-chelate conjugates
10/27/2009US7608241 Radiolabeling method
10/27/2009US7608223 Blood testing apparatus
10/27/2009US7608219 Re-usable with an indicator that changes color in the presence of steam after a time
10/27/2009US7608180 Determining concentration of hydrogen peroxide using organic quaternary ammonium or phosphonium ferricyanide compound which in reduced form functions as mediator specific to hydrogen peroxide; detected electrochemically at potential of -400 mV (Ag/AgCl) where oxidation of common interferants is avoided
10/27/2009CA2539510C Size-controlled macromolecule
10/27/2009CA2372085C L-ribo-lna analogues
10/27/2009CA2349529C Pge synthase and methods and means for modulating its activity
10/27/2009CA2341434C Pyrrolobenzodiazepine compounds
10/27/2009CA2328904C Novel (poly)peptides which represent the epitopes of the human herpesvirus type 8
10/27/2009CA2305738C Thermal processor measurement using simulated food particles
10/27/2009CA2202154C Methods for drug screening
10/25/2009CA2664713A1 Method for modeling recovery assisted by polymer injection
10/22/2009WO2009129549A2 Babesia microti genomic clones containing novel antigens useful in the diagnosis of babesiosis
10/22/2009WO2009129521A2 Immunodominant mycobacterium tuberculosis peptides from cell wall proteins for early diagnosis and immunization
10/22/2009WO2009129495A1 Use of nitrated lipids for treatment of lipid disorders and obesity, and lipid- and obesity-related conditions
10/22/2009WO2009129472A2 Methods of labeling biological samples
10/22/2009WO2009129454A2 Predicting risk of major adverse cardiac events
10/22/2009WO2009129333A1 Methods for enhancing the efficacy of vascular disrupting agents
10/22/2009WO2009129220A2 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
10/22/2009WO2009129173A2 Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
10/22/2009WO2009129018A1 Analysis of amino acid copolymer compositions
10/22/2009WO2009128978A1 Methods for detecting organisms and enzymatic reactions using raman spectroscopy
10/22/2009WO2009128956A1 Use of a steroid profile in ovarian follicular fluid for diagnosis, prognosis and determining strategies for treatment
10/22/2009WO2009128953A2 Genetic variants in a hypertension susceptibility gene stk39 and uses thereof
10/22/2009WO2009128938A1 Hydrodynamic focusing for analyzing rectangular microbeads
10/22/2009WO2009128787A1 Method and system for measuring a composition in a blood fluid
10/22/2009WO2009128774A1 Assay method and device
10/22/2009WO2009128610A2 Cell labeling and imaging using multifunctional perfluorocarbon nanoemulsion
10/22/2009WO2009128557A1 Electrochemical immunoassay
10/22/2009WO2009128483A1 Cell selection apparatus, and cell selection method using the same
10/22/2009WO2009128448A1 Novel protein capable of binding to hyaluronic acid, and method for measurement of hyaluronic acid using the same
10/22/2009WO2009128399A1 Oligonucleotide probe and microarray for determination of genome type of bk virus
10/22/2009WO2009128257A1 Method for evaluation or selection of adiponectin secretion regulator
10/22/2009WO2009128209A1 Detection method and detection system
10/22/2009WO2009128056A2 A method for screening compounds
10/22/2009WO2009127913A1 Methods for screening compounds for treating and/or preventing an hepatitis c virus infection
10/22/2009WO2009127881A1 Anti-areg/hb-egf antibodies and treatment
10/22/2009WO2009127855A1 Use of a monophosphate ester of a phthalein compound as a substrate for tartrate-resistant acid phosphatase b5 (trap 5b)
10/22/2009WO2009127846A1 Detection of gaseous halogens
10/22/2009WO2009127693A1 Methods for screening compounds for treating and/or preventing an hepatitis c virus infection
10/22/2009WO2009127619A1 Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer
10/22/2009WO2009127249A1 Method for identifying compounds suitable for stimulation of stem cell production in skin
10/22/2009WO2009127229A1 Gassing head and system
10/22/2009WO2009127094A1 The elisa kit for detecting lincomycin
10/22/2009WO2009127073A1 Cosmetic preparation tailored to an individual and method for the production thereof
10/22/2009WO2009127048A1 Method of treating demyelinating diesase
10/22/2009WO2009127046A1 Prostate specific membrane antigen antibodies and antigen binding fragments
10/22/2009WO2009127024A1 Process, portable equipment and device for in vitro, one-step photometric determination of hemoglobin concentration in a diluted blood sample
10/22/2009WO2009108866A3 Microrna signatures associated with cytogenetics and prognosis in acute myeloid leukemia (aml) and uses thereof
10/22/2009WO2009107069A3 Micro-electrode array based on optically transparent polymeric conductive materials, and method for the manufacturing thereof
1 ... 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 ... 3937